Clinical significance of Aspergillus sensitisation in bronchial asthma

Mycoses

Volumn 54, Issue 5, 2011, Pages

  Agarwal, Ritesh ^a   Noel, Vijay ^a   Aggarwal, Ashutosh N ^a   Gupta, Dheeraj ^a   Chakrabarti, Arunaloke ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

ABPA; Allergic bronchopulmonary aspergillosis; Aspergillus; Asthma; Fungal sensitisation; SAFS

Indexed keywords

ADULT; ANAMNESIS; ARTICLE; ASPERGILLUS; ASTHMA; ASTHMA CONTROL TEST; CLINICAL ASSESSMENT; CROSS-SECTIONAL STUDY; DISEASE CONTROL; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MINI ASTHMA QUALITY OF LIFE QUESTIONNAIRE; PHYSICAL EXAMINATION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; SCORING SYSTEM; SENSITIZATION; SKIN TEST;

ADULT; ASPERGILLUS; ASTHMA; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERSENSITIVITY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SKIN TESTS; VIRUSES, UNCLASSIFIED;

ASPERGILLUS;

EID: 80052795840     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/j.1439-0507.2010.01971.x     Document Type: Article

References (57)

1. Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention. URL, [accessed on 15 March 2010].
2. Denning DW, O'Driscoll BR, Powell G et al. Randomized controlled trial of oral antifungal treatment for severe asthma with fungal sensitization: The Fungal Asthma Sensitization Trial (FAST) study. Am J Respir Crit Care Med 2009; 179: 11-18.
3. Herbert FA, Weimer N, Salkie ML. RAST and skin test screening in the investigation of asthma. Ann Allergy 1982; 49: 311-4.
4. Burrows B, Martinez FD, Halonen M, Barbee RA, Cline MG. Association of asthma with serum IgE levels and skin-test reactivity to allergens. N Engl J Med 1989; 320: 271-7.
5. Kalliel JN, Goldstein BM, Braman SS, Settipane GA. High frequency of atopic asthma in a pulmonary clinic population. Chest 1989; 96: 1336-40.
6. Miles J, Cayton R, Ayres J. Atopic status in patients with brittle and non-brittle asthma: a case-control study. Clin Exp Allergy 1995; 25: 1074-82.
7. Reddy RC. Severe asthma: approach and management. Postgrad Med J 2008; 84: 115-20.
8. Denning DW, O'Driscoll BR, Hogaboam CM, Bowyer P, Niven RM. The link between fungi and severe asthma: a summary of the evidence. Eur Respir J 2006; 27: 615-26.
9. Woodcock A, Forster L, Matthews E et al. Control of exposure to mite allergen and allergen-impermeable bed covers for adults with asthma. N Engl J Med 2003; 349: 225-36.
10. Agarwal R Controversies in allergic bronchopulmonary aspergillosis. Int J Respir Care 2010; 5.
11. Zureik M, Neukirch C, Leynaert B, Liard R, Bousquet J, Neukirch F. Sensitisation to airborne moulds and severity of asthma: cross sectional study from European Community respiratory health survey. BMJ 2002; 325: 411-4.
12. Targonski PV, Persky VW, Ramekrishnan V. Effect of environmental molds on risk of death from asthma during the pollen season. J Allergy Clin Immunol 1995; 95: 955-61.
13. Black PN, Udy AA, Brodie SM. Sensitivity to fungal allergens is a risk factor for life-threatening asthma. Allergy 2000; 55: 501-4.
14. Schwartz HJ, Citron KM, Chester EH et al. A comparison of the prevalence of sensitization to Aspergillus antigens among asthmatics in Cleveland and London. J Allergy Clin Immunol 1978; 62: 9-14.
15. Maurya V, Gugnani HC, Sarma PU, Madan T, Shah A. Sensitization to Aspergillus antigens and occurrence of allergic bronchopulmonary aspergillosis in patients with asthma. Chest 2005; 127: 1252-9.
16. Agarwal R, Gupta D, Aggarwal AN, Behera D, Jindal SK. Allergic bronchopulmonary aspergillosis: lessons from 126 patients attending a chest clinic in north India. Chest 2006; 130: 442-8.
17. Agarwal R, Gupta D, Aggarwal AN, Saxena AK, Chakrabarti A, Jindal SK. Clinical significance of hyperattenuating mucoid impaction in allergic bronchopulmonary aspergillosis: an analysis of 155 patients. Chest 2007; 132: 1183-90.
18. Agarwal R, Aggarwal AN, Gupta D, Jindal SK. Aspergillus hypersensitivity and allergic bronchopulmonary aspergillosis in patients with bronchial asthma: systematic review and meta-analysis. Int J Tuberc Lung Dis 2009; 13: 936-44.
19. Agarwal R, Gupta D, Aggarwal AN et al. Clinical significance of decline in serum IgE Levels in allergic bronchopulmonary aspergillosis. Respir Med 2010; 104: 204-10.
20. Langley SJ, Goldthorpe S, Craven M, Morris J, Woodcock A, Custovic A. Exposure and sensitization to indoor allergens: association with lung function, bronchial reactivity, and exhaled nitric oxide measures in asthma. J Allergy Clin Immunol 2003; 112: 362-8.
21. American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995; 152: 1107-36.
22. Aggarwal AN, Gupta D, Jindal SK. Development of a simple computer program for spirometry interpretation. J Assoc Physicians India 2002; 50: 567-70.
23. Jindal SK, Wahi PL Pulmonary function laboratory in the tropics: needs, problems and solutions. Lung Disease in the Tropics New York, NY: Marcel Dekker 1991: 523-42.
24. Schatz M, Sorkness CA, Li JT et al. Asthma Control Test: reliability, validity, and responsiveness in patients not previously followed by asthma specialists. J Allergy Clin Immunol 2006; 117: 549-56.
25. Javidan-Nejad C, Bhalla S. Bronchiectasis. Thorac Surg Clin 2010; 20: 85-102.
26. Juniper EF, Guyatt GH, Cox FM, Ferrie PJ, King DR. Development and validation of the Mini Asthma Quality of Life Questionnaire. Eur Respir J 1999; 14: 32-38.
27. O'Hollaren M, Yunginger J, Offord K et al. Exposure to an aeroallergen as a possible precipitating factor in respiratory arrest in young patients with asthma. N Engl J Med 1991; 324: 359-63.
28. Peat JK, Tovey E, Mellis CM, Leeder SR, Woolcock AJ. Importance of house dust mite and Alternaria allergens in childhood asthma: an epidemiological study in two climatic regions of Australia. Clin Exp Allergy 1993; 23: 812-20.
29. Nelson HS, Szefler SJ, Jacobs J, Huss K, Shapiro G, Sternberg AL. The relationships among environmental allergen sensitization, allergen exposure, pulmonary function, and bronchial hyperresponsiveness in the Childhood Asthma Management Program. J Allergy Clin Immunol 1999; 104: 775-85.
30. Neukirch C, Henry C, Leynaert B, Liard R, Bousquet J, Neukirch F. Is sensitization to Alternaria alternata a risk factor for severe asthma? A population-based study. J Allergy Clin Immunol 1999; 103: 709-11.
31. Roux P, Smit M, Weinberg EG. Seasonal and recurrent intensive care unit admissions for acute severe asthma in children. S Afr Med J 1993; 83: 177-9.
32. O'Driscoll BR, Hopkinson LC, Denning DW. Mold sensitization is common amongst patients with severe asthma requiring multiple hospital admissions. BMC Pulm Med 2005; 5: 4.
33. Niedoszytko M, Chelminska M, Jassem E, Czestochowska E. Association between sensitization to Aureobasidium pullulans (Pullularia sp) and severity of asthma. Ann Allergy Asthma Immunol 2007; 98: 153-6.
34. Matsuoka H, Niimi A, Matsumoto H et al. Specific IgE response to trichophyton and asthma severity. Chest 2009; 135: 898-903.
35. Gudmundsson G, Hunninghake GW. Interferon-gamma is necessary for the expression of hypersensitivity pneumonitis. J Clin Invest 1997; 99: 2386-90.
36. Agarwal R. Allergic bronchopulmonary aspergillosis. Chest 2009; 135: 805-26.
37. Agarwal R, Nath A, Aggarwal AN, Gupta D, Chakrabarti A. Aspergillus hypersensitivity and allergic bronchopulmonary aspergillosis in patients with acute severe asthma in a respiratory intensive care unit in North India. Mycoses 2010; 53: 138-43.
38. Agarwal R, Hazarika B, Gupta D, Aggarwal AN, Chakrabarti A, Jindal SK Aspergillus hypersensitivity in patients with chronic obstructive pulmonary disease: COPD as a risk factor for ABPA? Med Mycol 2010; doi:10.3109/13693781003743148.
39. Liang KL, Su MC, Jiang RS. Comparison of the skin test and ImmunoCAP system in the evaluation of mold allergy. J Chin Med Assoc 2006; 69: 3-6.
40. O'Driscoll BR, Powell G, Chew F et al. Comparison of skin prick tests with specific serum immunoglobulin E in the diagnosis of fungal sensitization in patients with severe asthma. Clin Exp Allergy 2009; 39: 1677-83.
41. Malo JL, Paquin R. Incidence of immediate sensitivity to Aspergillus fumigatus in a North American asthmatic population. Clin Allergy 1979; 9: 377-84.
42. Ownby DR. Diagnostic tests in allergy. In: Lieberman P, Anderson JA (eds), Allergic Diseases: Diagnosis and Treatment. Totowa, NJ: Humana Press, 2007: 27-38.
43. Chakrabarti A, Sethi S, Raman DS, Behera D. Eight-year study of allergic bronchopulmonary aspergillosis in an Indian teaching hospital. Mycoses 2002; 45: 295-9.
44. Behera D, Guleria R, Jindal SK, Chakrabarti A, Panigrahi D. Allergic bronchopulmonary aspergillosis: a retrospective study of 35 cases. Indian J Chest Dis Allied Sci 1994; 36: 173-9.
45. Neas LM, Dockery DW, Burge H, Koutrakis p, Speizer FE. Fungus spores, air pollutants, and other determinants of peak expiratory flow rate in children. Am J Epidemiol 1996; 143: 797-807.
46. Delfino RJ, Zeiger RS, Seltzer JM et al. The effect of outdoor fungal spore concentrations on daily asthma severity. Environ Health Perspect 1997; 105: 622-35.
47. Salvaggio J, Seabury J, Schoenhardt FA. New Orleans asthma. V. Relationship between Charity Hospital asthma admission rates, semiquantitative pollen and fungal spore counts, and total particulate aerometric sampling data. J Allergy Clin Immunol 1971; 48: 96-114.
48. Newson R, Strachan D, Corden J, Millington W. Fungal and other spore counts as predictors of admissions for asthma in the Trent region. Occup Environ Med 2000; 57: 786-92.
49. Jenkins PF, Mullins JK, Davies BH, Williams DA. The possible role of aero-allergens in the epidemic of asthma deaths. Clin Allergy 1981; 11: 611-20.
50. Ward GW Jr, Woodfolk JA, Hayden ML, Jackson S, Platts-Mills TA. Treatment of late-onset asthma with fluconazole. J Allergy Clin Immunol 1999; 104: 541-6.
51. Abruzzo GK, Fromtling RA, Turnbull TA, Giltinan DM. Effects of bifonazole, fluconazole, itraconazole, and terbinafine on the chemiluminescence response of immune cells. J Antimicrob Chemother 1987; 20: 61-68.
52. Pawelec G, Jaschonek K, Ehninger G. The anti-fungal agent itraconazole exerts immunosuppressive effects on alloreactivity but not on natural immunity in vitro. Int J Immunopharmacol 1991; 13: 875-9.
53. Pawelec G, Ehninger G, Rehbein A, Schaudt K, Jaschonek K. Comparison of the immunosuppressive activities of the antimycotic agents itraconazole, fluconazole, ketoconazole and miconazole on human T-cells. Int J Immunopharmacol 1991; 13: 299-304.
54. Kim JH, Ahn YK. The effects of itraconazole on the immune responses in ICR mice. J Toxicol Sci 1994; 19: 7-15.
55. Kanda N, Enomoto U, Watanabe S. Anti-mycotics suppress interleukin-4 and interleukin-5 production in anti-CD3 plus anti-CD28-stimulated T cells from patients with atopic dermatitis. J Invest Dermatol 2001; 117: 1635-46.
56. Ausaneya U, Kawada A, Aragane Y. Itraconazole suppresses an elicitation phase of a contact hypersensitivity reaction. J Invest Dermatol 2006; 126: 1028-35.
57. Simitsopoulou M, Roilides E, Likartsis C et al. Expression of immunomodulatory genes in human monocytes induced by voriconazole in the presence of Aspergillus fumigatus. Antimicrob Agents Chemother 2007; 51: 1048-54.